Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-08-11
1991-12-17
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 11, 514 14, 514 15, 514 16, 514 17, A61K 3702, C07K 512, C07K 726
Patent
active
050735411
ABSTRACT:
A method of treating a mammal suffering from cancer by administering to the mammal somatostatin or an analog thereof, the analog being a hexapeptide analog or higher, in a dosage of at least 25 .mu.g/kg/day.
REFERENCES:
patent: 4133782 (1979-01-01), Vale, Jr. et al.
patent: 4211693 (1980-07-01), Rivier et al.
patent: 4282143 (1981-08-01), Sarantakis
patent: 4291022 (1981-09-01), Sandrin et al.
patent: 4328135 (1982-05-01), Sarantakis
patent: 4395403 (1983-07-01), Bauer et al.
patent: 4435385 (1984-03-01), Bauer et al.
patent: 4485101 (1984-11-01), Cov et al.
patent: 4650787 (1987-03-01), Schally et al.
patent: 4703034 (1987-10-01), Friedinger et al.
patent: 4816438 (1989-03-01), Spiess et al.
patent: 4820811 (1989-04-01), Teng
Verber, "A Super Active Cyclic Hexapeptide Analog of Somatostatin," Life Sciences, 34: 1371-1378 (1984).
Cai, "Synthesis and Evaluation of Activities of Octapeptide Analogs of Somatostatin," Nature, 292: 55-58 (1981).
Lamberts et al., "Potential Role of Somatostatin Analogues in the Treatment of Cancer," European J. of Clin. Invest., 17: 281-287 (1987).
Setyono-Han et al., "Direct Inhibitory Effects of Somatostatin (Analogues on the Growth of Human Breast Cancer Cells," Cancer Research, 47: 1566-15 (1987).
Moreau et al., "Therapeutic Advances and Perspectives," Life Sciences, 84: 7275-7279 (1987).
Schally et al., "Somatostatin Analogs as Adjuncts to Agonists of Luteinizing Hormone-Releasing Hormone in the Treatment of Experimental Prostate Cancer," Proc. Natl. Acad. Sci., 84: 7275-7279 (1987).
Reubi et al., "Somatostatin Receptors in Human Endocrine Tumors," Cancer Research, 47: 551-558 (1987).
Murphy et al., Chem. Abstracts 104:28911x (1986).
Torres-Alman (Abstract) Chem. Abstracts 102:160733 (1985).
CA Vuk-Pavlovic et al. 97:85726s, vol. 97 1982.
CA Pless et al., 106:770h, vol. 106, 1987.
Bogden Arthur E.
Coy David H.
Moreau Jacques-Pierre
Taylor John E.
Administrators of the Tulane Educational Fund
Biomeasure Inc.
Lee Lester L.
LandOfFree
Treatment of small cell lung cancer with somatostatin analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of small cell lung cancer with somatostatin analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of small cell lung cancer with somatostatin analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-835645